U of T, Moderna partner on research, tool development

The University of Toronto has announced that it is partnering with Moderna Inc on RNA science and technology research and the development of tools to address infectious disease. The collaboration will focus on studying the prevention and treatment of infectious diseases, including Risk Group 3 pathogens, with research taking place at U of T’s Lash Miller Chemical Laboratories and the Combined Containment Level 3 facility. “It is not every day that an opportunity presents to combine a world-class life sciences research community and a disruptive biological innovator,” said U of T VP, research and innovation and strategic initiatives Leah Cowen. “We are proud to say that today is one such day.” U of T| BioSpace Note: Archived stories may contain dead links or be missing source links.